RPG Life Sciences' (NSE:RPGLIFE, BOM:532983) profit surged to 1.17 billion Indian rupees in the fiscal fourth quarter ended March 31 against 132.4 million rupees a year ago.
Earnings per share climbed to 70.96 rupees compared with the year-ago figure of 8.01 rupees, according to a Monday filing to the Indian stock exchanges by the pharmaceuticals manufacturer.
Revenue from operations in fiscal Q4 increased to 1.43 billion rupees from 1.27 billion rupees a year earlier.
The board of directors recommended a final dividend of 20 rupees per equity share of the face value of 8 rupees each for the fiscal year ended March 31.
A special dividend of 4 rupees per equity share of face value of 8 rupees each has also been recommended on account of significant exceptional profit on the assignment of land.
The company's shares were up nearly 3% in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。